CIK 0001956827SIC 2834· Pharmaceutical Preparations

Abivax S.A. (ABVX, AAVXF)

Name: Abivax S.A. (ABVX, AAVXF) — SEC EDGAR Filings (CIK 0001956827)
Creator: Abivax S.A. (ABVX, AAVXF)
License: https://www.sec.gov/foia/about-foia

1 SEC EDGAR filings indexed (CIK 0001956827) across 1 form type.

Filing profile

Abivax S.A. (ABVX, AAVXF) has 1 SEC filing indexed on SecFilingDex, across 1 form type, all filed on July 2, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the 424B5 (Prospectus supplement) with 1 filing — Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement. 1 of these filing was disclosed in the twelve months to July 2, 2026.

Disclosure mix

1424B5Prospectus supplement · event-driven

Profile derived from 1 indexed filing; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

2026-07-02424B50001193125-26-294491

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1956827&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.